Traditional Chinese medicine composition for treating chronic obstructive pulmonary disease and preparation method thereof

Abstract

The invention provides a traditional Chinese pharmaceutical composition for curing chronic obstructive pulmonary disease and a preparation method thereof. The traditional Chinese pharmaceutical composition is prepared from the bulk drugs in parts by weight: 10-15 parts of radix et rhizoma ginseng, 5-10 parts of almond, 10-15 parts of fructus perillae, 10-15 parts of fritillariae thunbergii bulbus, 1-3 parts of herba asari, 10-15 parts of fructus aurantii immaturus, 10-15 parts of radix platycodonis, 5-10 parts of rhizoma pinelliae praeparatum, 10-15 parts of pericarpium citri reticulatae, 15-20 parts of poria cocos, 10-25 parts of radix et rhizoma salvia miltiorrhizae, 10-15 parts of Chinese angelica, 10-15 parts of radix paeoniae rubra and 5-10 parts of liquorice root. The preparation method is that the traditional Chinese pharmaceutical composition is prepared into decoction or pills. The traditional Chinese pharmaceutical composition pays attentions to curing lungs, spleen and kidneys, increases therapy of reducing phlegm and removing stasis, has effects of tonifying qi, activating blood, diffusing the lungs, relieving a cough, eliminating phlegm and freeing channels, can effectively relieve symptoms of chronic obstructive pulmonary disease and chronic cough, improves organism immunity of patients and improves the life quality of the patients.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a traditional Chinese medicine composition for treating chronic obstructive pulmonary disease and a preparation method thereof. Background technique [0002] Chronic obstructive pulmonary disease (COPD) is a common and important chronic respiratory disease, with cough, wheezing, expectoration, and shortness of breath as the main clinical manifestations. COPD is characterized by airflow limitation, not fully reversible, and progressive development, and is mostly caused by the development of chronic bronchitis, asthma, and emphysema. In the late stage of COPD, cor pulmonale often occurs, and death is often caused by infection and aggravated respiratory failure. [0003] COPD has a large number of patients and a high mortality rate. Due to the slow development of the disease, it seriously affects the working ability and quality of life of patients. COPD is a chronic progressive disease, so...

AI Technical Summary

Problems solved by technology

Clinically, most patients with COPD in the acute stage are treated with western medicine alone, but the improvement of the symptoms of coughing and asthma is limited.